Juvenile Idiopathic Arthritis (JIA) Prevalence: Updated Epidemiology

Juvenile Idiopathic Arthritis (JIA) — formerly JRA — affects approximately 1 in 1,000 children (100 per 100,000) in North America and Europe. Prevalence varies by subtype, region, and case definition.

Subtype Distribution (ILAR Classification)

• Oligoarticular (4–6 joints): ~50% — peak 2–4 yr, female predominance, high uveitis risk
• Polyarticular RF-negative: ~25%
• Systemic (Still's disease): ~10% — fever, rash, organ involvement
• Enthesitis-related: ~10% — HLA-B27 associated, male predominance
• Psoriatic: ~5%
• Undifferentiated: ~5%

Geographic & Demographic Variation

• Higher in northern latitudes (vitamin D hypothesis).
• Lower in Asian and African populations (may reflect ascertainment).
• Female:male ratio ~2:1 overall (except ERA, systemic).

Incidence vs. Prevalence

• Incidence: ~10–20 per 100,000/year.
• Prevalence higher due to chronicity (many persist into adulthood).

Key Point

JIA is the most common chronic rheumatic disease of childhood. Early diagnosis by pediatric rheumatologist prevents joint damage, uveitis blindness, and growth impairment. Methotrexate + biologics (TNF, IL-6, IL-1 inhibitors) have transformed outcomes.